The US Food and Drug Administration’s top vaccine official overrode agency experts in May to recommend against the broad use ...

Federal documents show he disagreed with conclusions the benefits outweighed the risk of side effects, which are rare.

FDA vaccine head Vinay Prasad restricted Moderna and Novavax COVID vaccines to high-risk groups, overriding staff advice amid ...

The new memos from the Food and Drug Administration show how the agency’s vaccine chief, Dr. Vinay Prasad, personally ...

The new Nimbus COVID‑19 variant is on the rise and is known for its startling sore‑throat symptom dubbed “razor blade throat.

Recent vaccination announcements have led to some confusion. Four physicians weigh in on who should get vaccinated and when ...

CDC experts emphasized the need for COVID vaccination during pregnancy, showing that children under 6 months are vulnerable ...

Two new Omicron subvariants are gaining ground in the U.S. as some people report experiencing respiratory symptoms like ...

In patients with COVID-19, preexisting immunity and Omicron infection were associated with reduced disease severity and upper respiratory symptom presentation.

Cases of the recently identified Covid-19 variant NB 1.8.1. are rising. Some have dubbed the variant "razor blade throat" for ...

Investigators concluded that individuals with comorbidities experienced higher risks of severe COVID-19 outcomes during the ...

There was a decline in hospitalizations and in-hospital mortality due to COVID-19 between 2023 and 2024, a period spanning the XBB, JN.1, and KP eras.